Is your drug pipeline dominated by injectables? We can deliver combination products in our autoinjector platforms at pace! Come and talk to us! https://t.co/NZastv1oly
#SimplerSmarterBetter
Are you looking for a subcutaneous platform that is ready to be configured to your drug formulation, even those that are challenging? ArQ is ready to deliver your parenteral pipeline at pace.
https://t.co/6KJzxx8A7n
#SimplerSmarterBetter
Oval Medical Technologies is part of SMC Ltd. We are one organisation delivering an end-to-end autoinjector platform solution. Our integrated team means we offer pace, cost-effectiveness, and a single point of contact for all logistics.
#SimplerSmarterBetter#SMC
Does a flexible autoinjector platform for a variety of volumes and viscosities with a common assembly line and filling capabilities help de-risk your journey to the market? Check out Oval’s end to end solution: https://t.co/qIYQtNfwl6
#SimplerSmarterBetter#SMCLtd
Discover how our autoinjector expertise can accelerate your novel therapy to the clinic and how our integrated services can help with delivery of complex formulations and sterile manufacturing: https://t.co/7qxonbfkBv
#SimplerSmarterBetter#SMCLtd
Match your subcutaneous injection with our clinic ready ArQ autoinjector today. ArQ has a robust plastic primary drug container, which is safer under pressure than glass, meaning we can deliver higher viscosity formulations in our standard platform.
#SimplerSmarterBetter
Are you struggling to find an autoinjector platform to meet challenging volume or viscosity characteristics? Our primary drug containers are made of COC plastic, giving design and manufacturing freedom to meet those challenges.
#SimplerSmarterBetter
Our ArQ-Bios autoinjector platform has been developed to ensure patient-centricity whilst delivering high viscosity or large volume subcutaneous injections.
Speak to us today to find out more. https://t.co/pFR0d9IJvc
#SimplerSmarterBetter
Difficult to inject formulations? Our autoinjector platform, ArQ-Bios is designed for large volumes or high viscosity drug formulations. https://t.co/h91lepwrRb
Let Oval de-stress an autoinjector strategy for you.
#SimplerSmarterBetter
We would like to give a warm welcome to Uri Baruch, our new Managing Director here at Oval Medical technologies. Please read all about this exciting news in the press release here: https://t.co/TWf4my4URp
#SimplerSmarterBetter
Do you want to understand your formulation a bit better? Our in-house expertise and Injection Characterisation System can help. Contact us! https://t.co/UwIBwZgoKG
#SimplerSmarterBetter
Read our latest original research article in Springer Nature “Journal of Pharmaceutical Sciences” by Asmita Khanolkar, Susie White and Elizabeth Margerison titled “A Novel Method to Optimize Drug Delivery for Parenteral Products." Pharm Res (2023).https://t.co/I6OtjqU4dI
Differentiated subcutaneous Autoinjector? ArQ and ArQ-Bios platforms cover the broadest range of volumes and viscosities you will need.
#SimplerSmarterBetter
Do you need a CDMO for clinical sterile fill-finish? Let Cambridge Pharma, part of our SMC Group take the stress out of your journey to the clinic. We have availability; contact us! https://t.co/RzOpSInESa
Are you developing a challenging injectable formulation? Find out how we match formulation characteristics to our autoinjector platforms here: https://t.co/6ZDGhTsTbl
#SimplerSmarterBetter
Couldn't make the successful BIO-Europe Spring meeting? Find out more about our autoinjector platforms here: https://t.co/H9xUZWujY6
#SimplerSmarterBetter
Need a first-class facility to sterile fill-finish your clinical drug product? Talk to our associate company Cambridge Pharma, a CDMO looking to de-stress your journey to the clinic. We have a few slots available!
#SMC#Oval#Cambridge Pharma
Crisis? Emergency ? or just a regular intramuscular injection? The ArQ-Vita i.m platform is simpler, smarter and better for patients. That means for you too, right?
#smc#oval#cpl
We are exhibiting at BioEurope next week, come and meet us on stand 105 to discuss the capabilities of our autoinjector platforms.
#SimplerSmarterBetter